arrows arrow-right arrow-left menu search rss youtube linkedin twitter facebook instagram arrow-play linkedIn

In the News

NBC4 - The U.S. Food and Drug Administration has approved Columbus-based non-profit Battelle’s request to begin sterilizing surgical masks for reuse during the COVID-19 coronavirus pandemic. The FDA has amended its initial approval, granted early Sunday, now allowing Battelle to sterilize the N95 surgical masks without a daily limit.

USA Today - After a day of pressure from Ohio Gov. Mike DeWine, the U.S. Food and Drug Administration late Sunday rewrote rules to allow full application of a potentially game-changing Battelle technology to sterilize protective masks worn by those treating coronavirus victims.

The Columbus Dispatch - After a day of pressure from Ohio Gov. Mike DeWine, the U.S. Food and Drug Administration late Sunday rewrote rules to allow full application of a potentially game-changing Battelle technology to sterilize protective masks worn by those treating coronavirus victims.

FierceBiotech - Battelle received an emergency go-ahead from the FDA over the weekend to deploy its decontamination system for personal protective equipment (PPE), allowing healthcare workers to clean and reuse scarce N95 respirator masks.

The Columbus Dispatch - As the number of coronavirus cases continued to grow Saturday, Gov. Mike DeWine pleaded with the U.S. Food and Drug Administration to immediately approve an emergency-use permit for a potentially game-changing invention from Columbus-based research lab Battelle that could help with the shortage of masks for health-care workers.

Columbus Public Radio - WOSU - “We’re looking at the Battelle CCDS Critical Care Decontamination System™ that we’ve developed to be able to decontaminate PPE for health care workers on the frontline,” says Battelle researcher Will Richter. The Critical Care Decontamination System is the first of its kind, capable of cleaning up to 80,000 pieces of PPE (personal protective equipment) at a time. Battelle's system was designed to be modular so it can be easily shipped, and scaled up – the more units in one area, the more rapidly they will be able to clean mass amounts of PPE and return them to the hospitals.

Columbus Business First - Husted: Battelle awaiting FDA approval to deploy mask-sterilizing technology

Cincinnati Public Radio - WVXU - Several Ohio hospitals are working with Battelle, a research institute based in Columbus, to find ways to clean PPE so they can be reused. Ohio Health, Wexner Medical Center and Mount Carmel are all working together to collect donations of PPE. They've opened drive-up drop-off sites that allow people to donate supplies without ever leaving their vehicles.

WOSU Public Meida - Gov. Mike DeWine on Monday declared a state of emergency after Ohio officials identified the first three cases of COVID-19 in the state. If the coronavirus spreads throughout the state as it has in others, like Washington, that will likely mean quarantine and a major change in how work is done.

WSYX/WTTE ABC 6 - Several Central Ohio companies are telling employees to work from home as COVID-19 concerns hit Ohio. Battelle - Starting Friday, employees who can work from home were told to do so.

Columbus Dispatch - Ohio’s counties will get this week their portion of face masks, gowns and other medical equipment from the Strategic National Stockpile, the state’s public health director said Monday as she warned the additions won’t be enough to stem shortages at hospitals across the state.

Assembled Chemical Weapons Alternatives - Scientists created special tools, called thermal dosimeters, for testing Metal Parts Treater temperatures in the Blue Grass main plant.

GovCon Wire - Executive Mosaic is honored to present Lou Von Thaer, president and CEO of Battelle, as an inductee into the 2020 Wash100 Award.

Columbus Business First - Heintz went to college at the University of Michigan (you'll have to listen to the episode for her surprising take on Ohio State football fans) and tried out a few different areas of study before falling in love with chemistry.

MIT Technology Review - Synthetic versions of the deadly virus could help test treatments. But what are the risks when viruses can be synthetized from scratch?

GovCon Wire - Stephen Steinour, president and CEO of bank holding company Huntington Bancshares, has joined the board of directors of Battelle.

Global Biodefense - Battelle Memorial Institute has been awarded a $7,483,871 contract option for further research and development of an advanced networked biological threat sensor as part of the Defense Advanced Research Projects Agency’s SIGMA+ program.

Industry Week - The network of 18 STEM organizations across 16 states provides an accessible platform to share, analyze and disseminate quality STEM education tools.

MIT Technology Review - A new DARPA research program is developing brain-computer interfaces that could control “swarms of drones, operating at the speed of thought.” What if it succeeds?

GovCon Wire - Dedrone has acquired the rights to a counter-small unmanned aerial system from Battelle and established a consultancy business unit to offer sUAS detection and mitigation support to the Department of Defense.

Media Contacts

Katy Delaney
Director, Media Relations
Office: 1.614.424.7208
Email: delaneyk@battelle.org 


T.R. Massey

Senior Media Specialist
Office: 1.614.424.5544 
Email: masseytr@battelle.org